MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2018 International Congress

    A German-Austrian multicenter, non-interventional, prospective study for the treatment with abobotulinumtoxinA injections in naïve and previously treated patients suffering from cervical dystonia

    W. Jost, A. Schramm, M. Müngersdorf, A. Stenner, P. Schwingenschuh, P. Maisonobe, M. Koch, B. Haslinger (Wolfach, Germany)

    Objective: In this prospective, multicenter, non-interventional study (NCT01840462) the primary objective was effectiveness of abobotulinumtoxinA in BoNT treatment-naïve and previously treated subjects after two injection…
  • 2018 International Congress

    Pallidotomy in dystonia –Experience from a tertiary care centre in a developing country

    K. Garg, M. Singh, V. Goyal, R. Sharma (New Delhi, India)

    Objective: The objective of the present study was to determine the outcomes of pallidotomy in dystonia patients in a developing nation. Background: Pallidotomy is one…
  • 2018 International Congress

    Improvement in Patient Perceived Quality of Life with DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia

    C. Comella, A. Brashear, J. Jankovic, D. Truong, A. Patel, M. Evatt, N. Kapa, Y. Liu, T. Nguyen-Cleary (Chicago, IL, USA)

    Objective: We describe the quality of life outcome from an open-label trial of daxibotulinumtoxinA for injection (Daxi) in cervical dystonia (CD) as measured by the…
  • 2018 International Congress

    Good response to bilateral GPI-DBS after 2 years in generalized dystonia due to a mutation in the KMT2B gene (DYT28)

    A. Garrido, C. Simonet, MJ. Martí, B. Pérez-Dueñas, J. Rumià, F. Valldeoriola (Barcelona, Spain)

    Objective: To report a case of generalized primary dystonia due to a mutation in the histone methyltransferase gene (KMT2B) treated with globus pallidus interna deep…
  • 2018 International Congress

    Education in hyperkinetic movement disorders in Cameroonian health providers

    M.H.G. Monje, M.M. Kurtis, M. Molina, C. Delgado-Suárez, P. Gómez-Iglesias, I. García-Morales, D. García-Azorín (Móstoles, Madrid, Spain)

    Objective: To evaluate the educational gaps in hyperkinetic movement disorders among a widely-varied sample of Cameroonian health providers and improve understanding through a practical training…
  • 2018 International Congress

    Phenomenology and management of subthalamic stimulation-induced dyskinesia in a video case series of patients with isolated dystonia

    K. Dodenhoff, I. Bledsoe, M. San Luciano, M. Volz, L. Markun, P. Starr, J. Ostrem (San Francisco, CA, USA)

    Objective: To document with videotaped observations, 3 patients with isolated dystonia who experienced stimulation-induced dyskinesia (SID) following subthalamic nucleus (STN) deep brain stimulation (DBS). Background:…
  • 2018 International Congress

    Effect of lidocaine injection into the external oblique muscle on camptocormia and the lateral slant posture in patient with Parkinson’s disease

    Y. Higashi, M. Tabata, T. Tabuchi, Y. Hattori (Himeji, Japan)

    Objective: Camptocormia (CC) is one of the abnormal posture of Parkinson's disease (PD) patients, described as a severe forward flexion of the trunk. In this…
  • 2018 International Congress

    Response to botulinum toxin in adult onset lower limb dystonia

    D. Ehrlich, K. Alter, B. Karp (Bethesda, MD, USA)

    Objective: To describe the response to treatment with botulinum toxin in a cohort with adult onset lower limb dystonia. Background: Adult onset, lower limb dystonia…
  • 2018 International Congress

    Botulinum toxin injection for Pisa syndrome in Parkinson’s disease

    CA. Artusi, M. Zibetti, P. Barbero, M. Busso, S. Bortolani, S. De Mercanti, P. Arnoffi, M. Fabbri, A. Merola, L. Lopiano (Torino, Italy)

    Objective: We sought to assess the clinical efficacy of Botulinum toxin (BoNT) injection for Pisa syndrome (PS) using a combined Magnetic Resonance Imaging (MRI)-, Ultrasonography…
  • 2018 International Congress

    Paroxysmal multifocal dystonia with hemiplegic migraine possibly related to novel CACNA1A mutation

    A. Hannoun, K. Smith (Worcester, MA, USA)

    Objective: To report a case of a unique clinical presentation of hemiplegic migraine associated with paroxysmal multifocal dystonia possibly related to a novel CACNA1A mutation.…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley